Published Date: 30-Sep-2022
Industry Insights | Market Trends | Highest number of Tables | 24/7 Analyst Support
According to a new report, published by KBV research, The Global Protease Market size is expected to reach $5 billion by 2028, rising at a market growth of 5.5% CAGR during the forecast period.
The Food & Beverages segment is showcasing CAGR of 5.3% during (2022 - 2028). The protease breaks down the protein into tiny peptides as well as amino acids, which reduces the precipitate phenomenon in the beverage and boosts the flavoring ingredients. The primary roles of protease are to raise dough volume, increase dough toughness, decrease gluten in the flour, and enhance the flexibility of gluten.
The Microbes segment acquired maximum revenue share in the Global Protease Market by Source in 2021 thereby, achieving a market value of $3.0 billion by 2028. The increase in protease production by bacteria is responsible for this. Utilizing microbial sources makes it possible to produce proteases at an industrial scale, and this massive level of production helps to meet the need for proteases across numerous industries.
The North America market dominated the Global Protease Market by Region in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $1.7 billion by 2028. The Europe market is exhibiting a CAGR of 5% during (2022 - 2028). Additionally, The Asia Pacific market would showcase a CAGR of 6.2% during (2022 - 2028).
Full Report: https://www.kbvresearch.com/protease-market/
The market research report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the globe with country wise analysis in each discussed region. The key impacting factors of the market have been discussed in the report with the elaborated company profiles of Advanced Enzyme Technologies Limited, Amano Enzyme, Inc., Associated British Foods PLC, BASF SE, Dupont De Nemours, Inc., Koninklijke DSM N.V., Novozymes A/S, Chr. Hansen Holding A/S, Biocatalysts Limited (Brain AG), and Dyadic International, Inc.
Unique Offerings from KBV Research